Crispr Therapeutics shares owned by D. E. Shaw & Co
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by D. E. Shaw & Co
from 13F filings
Historical chart of D. E. Shaw & Co investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by D. E. Shaw & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $28M | 431k | 64.81 |
| 2025-06-30 | $6.5M | 134k | 48.64 |
| 2025-03-31 | $1.7M | 51k | 34.03 |
| 2024-12-31 | $2.9M | 75k | 39.36 |
| 2024-09-30 | $5.8M | 124k | 46.98 |
| 2024-06-30 | $5.7M | 106k | 54.01 |
| 2024-03-31 | $28M | 406k | 68.16 |
| 2023-12-31 | $18M | 285k | 62.60 |
| 2023-09-30 | $4.7M | 103k | 45.39 |
| 2023-06-30 | $5.8M | 103k | 56.14 |
| 2023-03-31 | $6.6M | 145k | 45.23 |
| 2022-12-31 | $11M | 262k | 40.65 |
| 2022-09-30 | $12M | 176k | 65.35 |
| 2022-06-30 | $13M | 206k | 60.77 |
| 2022-03-31 | $15M | 236k | 62.76 |
| 2021-12-31 | $12M | 163k | 75.79 |
| 2021-09-30 | $11M | 99k | 111.94 |
| 2021-06-30 | $21M | 129k | 161.90 |
| 2021-03-31 | $26M | 213k | 121.85 |
| 2020-12-31 | $46M | 303k | 153.11 |
| 2020-09-30 | $25M | 297k | 83.65 |
| 2020-06-30 | $26M | 359k | 73.48 |
| 2020-03-31 | $12M | 286k | 42.42 |
| 2019-12-31 | $1.1M | 19k | 60.92 |
| 2019-09-30 | $823k | 20k | 40.96 |
| 2019-06-30 | $331k | 7.0k | 47.16 |
| 2019-03-31 | $234k | 6.6k | 35.71 |
| 2018-12-31 | $1.6M | 55k | 28.57 |
| 2018-09-30 | $245k | 5.5k | 44.26 |
| 2018-06-30 | $334k | 5.7k | 58.73 |
| 2018-03-31 | $731k | 16k | 45.70 |